0001079973-23-000852.txt : 20230609
0001079973-23-000852.hdr.sgml : 20230609
20230609163410
ACCESSION NUMBER: 0001079973-23-000852
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rhodes William E.
CENTRAL INDEX KEY: 0001532276
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37367
FILM NUMBER: 231005871
MAIL ADDRESS:
STREET 1: C/O OPGEN, INC.
STREET 2: 9717 KEY WEST AVE., SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPGEN INC
CENTRAL INDEX KEY: 0001293818
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 061614015
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9717 KEY WEST AVENUE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-869-9683
MAIL ADDRESS:
STREET 1: 9717 KEY WEST AVENUE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
ownership.xml
X0407
4
2023-06-07
0
0001293818
OPGEN INC
OPGN
0001532276
Rhodes William E.
C/O OPGEN, INC. 9717 KEY WEST AVE.,
SUITE 100
ROCKVILLE
MD
20850
1
0
0
0
0
Common Stock
2023-06-07
4
A
0
1500
0.00
A
3000
D
Represents an award of restricted stock units vesting on the first anniversary of the date of grant, or if earlier, the date of the 2024 annual meeting of stockholders, subject to acceleration and vesting if the director leaves the Board of Directors in connection with a change in control of OpGen, Inc. (the "Company").
The number of restricted stock units and shares reflects the application of the twenty-for-one reverse stock split effected by the Company on January 5, 2023.
/s/ Oliver Schacht, attorney-in-fact for William E. Rhodes, III
2023-06-09